Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K H Roux

Showing results (51-60 of 58) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 58 results.
Proceedings of the National Academy of Sciences of the United States of America|September 30, 1998
Structural analysis of the nurse shark (new) antigen receptor (NAR): molecular convergence of NAR and unusual mammalian immunoglobulinsK H Roux, A S Greenberg, L Greene, et al.
Arthritis and Rheumatism|January 1, 1997
Cross-reactivity of human IgG anti-F(ab')2 antibody with DNA and other nuclear antigensR C Williams, C C Malone, K Cimbalnik, et al.
Molecular Immunology|August 1, 1994
Characterization of biosynthetic IgG oligomers resulting from light chain variable domain duplicationK H Roux, W W Shuford, J W Finley, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|May 16, 2008
Pistachio vicilin, Pis v 3, is immunoglobulin E-reactive and cross-reacts with the homologous cashew allergen, Ana o 1L N Willison, P Tawde, J M Robotham, et al.
The Journal of Allergy and Clinical Immunology|September 7, 2001
A molecular model of type I allergy: identification and characterization of a nonanaphylactic anti-human IgE antibody fragment that blocks the IgE-FcepsilonRI interaction and reacts with receptor-bound IgES Laffer, E Hogbom, K H Roux, et al.
AIDS Research and Human Retroviruses|March 10, 2000
Parameters influencing measurement of the Gag antigen-specific T-proliferative response to HIV type 1 infectionD S Schiller, J M Binley, K H Roux, et al.
Transactions of the Association of American Physicians|January 1, 1990
Recombinant soluble CR1 suppressed complement activation, inflammation, and necrosis associated with reperfusion of ischemic myocardiumH F Weisman, T Bartow, M K Leppo, et al.
Science (New York, N.Y.)|July 13, 1990
Soluble human complement receptor type 1: in vivo inhibitor of complement suppressing post-ischemic myocardial inflammation and necrosisH F Weisman, T Bartow, M K Leppo, et al.
Pageof 6

Showing results (51-60 of 58) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 58 results.
Proceedings of the National Academy of Sciences of the United States of America|September 30, 1998
Structural analysis of the nurse shark (new) antigen receptor (NAR): molecular convergence of NAR and unusual mammalian immunoglobulinsK H Roux, A S Greenberg, L Greene, et al.
Arthritis and Rheumatism|January 1, 1997
Cross-reactivity of human IgG anti-F(ab')2 antibody with DNA and other nuclear antigensR C Williams, C C Malone, K Cimbalnik, et al.
Molecular Immunology|August 1, 1994
Characterization of biosynthetic IgG oligomers resulting from light chain variable domain duplicationK H Roux, W W Shuford, J W Finley, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|May 16, 2008
Pistachio vicilin, Pis v 3, is immunoglobulin E-reactive and cross-reacts with the homologous cashew allergen, Ana o 1L N Willison, P Tawde, J M Robotham, et al.
The Journal of Allergy and Clinical Immunology|September 7, 2001
A molecular model of type I allergy: identification and characterization of a nonanaphylactic anti-human IgE antibody fragment that blocks the IgE-FcepsilonRI interaction and reacts with receptor-bound IgES Laffer, E Hogbom, K H Roux, et al.
AIDS Research and Human Retroviruses|March 10, 2000
Parameters influencing measurement of the Gag antigen-specific T-proliferative response to HIV type 1 infectionD S Schiller, J M Binley, K H Roux, et al.
Transactions of the Association of American Physicians|January 1, 1990
Recombinant soluble CR1 suppressed complement activation, inflammation, and necrosis associated with reperfusion of ischemic myocardiumH F Weisman, T Bartow, M K Leppo, et al.
Science (New York, N.Y.)|July 13, 1990
Soluble human complement receptor type 1: in vivo inhibitor of complement suppressing post-ischemic myocardial inflammation and necrosisH F Weisman, T Bartow, M K Leppo, et al.
Pageof 6